Tag: U.S. Food and Drug Administration

Pharmazz’s Lyfaquin, approved by DGCI, proves wonder in managing massive blood loss and hypovolemic shock

The discovery of Lyfaquin as a resuscitative agent was made at Midwestern University in the USA and developed by Pharmazz to bring this product to the patient for the first time. The pharma major Pharmazz India has...